Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3 US Penny Stocks With Market Caps Over $10M To Consider

In This Article:

As investors navigate a mixed market landscape, with major indices showing varied performances amid a wave of earnings reports, the allure of smaller investment opportunities remains significant. Penny stocks, though often associated with speculative trading, still hold potential when backed by robust financials. These companies can offer unique growth prospects and value that larger firms may overlook. In this article, we explore several penny stocks that stand out for their financial strength and potential for long-term success.

Top 10 Penny Stocks In The United States

Name

Share Price

Market Cap

Financial Health Rating

BAB (OTCPK:BABB)

$0.8577

$6.52M

★★★★★★

QuantaSing Group (NasdaqGM:QSG)

$3.08

$121.59M

★★★★★★

ZTEST Electronics (OTCPK:ZTST.F)

$0.2799

$9.75M

★★★★★★

Imperial Petroleum (NasdaqCM:IMPP)

$3.03

$88.27M

★★★★★★

Permianville Royalty Trust (NYSE:PVL)

$1.43

$47.85M

★★★★★★

Golden Growers Cooperative (OTCPK:GGRO.U)

$4.50

$67.38M

★★★★★★

BTCS (NasdaqCM:BTCS)

$3.09

$51.01M

★★★★★★

Smith Micro Software (NasdaqCM:SMSI)

$1.35

$21.99M

★★★★★☆

CBAK Energy Technology (NasdaqCM:CBAT)

$0.9234

$83.69M

★★★★★☆

SideChannel (OTCPK:SDCH)

$0.038815

$9.04M

★★★★★★

Click here to see the full list of 706 stocks from our US Penny Stocks screener.

Let's dive into some prime choices out of the screener.

Cyclerion Therapeutics

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Cyclerion Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for serious diseases, with a market cap of $13.46 million.

Operations: Cyclerion Therapeutics, Inc. has not reported any revenue segments.

Market Cap: $13.46M

Cyclerion Therapeutics, Inc., a pre-revenue biopharmaceutical company with a market cap of US$13.46 million, recently filed a US$25 million Shelf Registration. Despite its unprofitability and negative return on equity, the company has seen significant reduction in losses over the past five years at an annual rate of 49.4%. However, it faces challenges with less than one year of cash runway and highly volatile share prices. The board is experienced, but management tenure data is insufficient to assess leadership stability fully. Cyclerion remains debt-free with short-term assets exceeding liabilities by US$2.8 million.

NasdaqCM:CYCN Debt to Equity History and Analysis as at Feb 2025
NasdaqCM:CYCN Debt to Equity History and Analysis as at Feb 2025

Smart Share Global

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Smart Share Global Limited is a consumer tech company offering mobile device charging services in the People's Republic of China, with a market cap of $296.92 million.